A radiologist is reviewing multiphasic computed tomography (CT) scans of the liver for several adult patients. Match each clinical and radiologic presentation with its most likely diagnosis.
- A 62-year-old man with a history of alcohol use disorder has a 3.5-cm liver mass demonstrating early arterial hyperenhancement and rapid contrast washout during the portal venous phase.Hepatocellular carcinoma
- A 29-year-old asymptomatic woman is found to have an incidental 4-cm liver lesion showing peripheral nodular enhancement on the arterial phase with progressive centripetal fill-in on delayed imaging.Hepatic hemangioma
- A 34-year-old woman on long-term oral contraceptives presents with acute abdominal pain; imaging reveals a 6-cm subcapsular liver lesion with heterogeneous enhancement and evidence of recent internal hemorrhage.Hepatic adenoma
- A 31-year-old healthy woman undergoes imaging for atypical abdominal pain, revealing a 5-cm liver mass with intense, uniform arterial enhancement and a central stellate scar.Focal nodular hyperplasia
Answer
The 62-year-old with early enhancement and venous washout matches Hepatocellular carcinoma. The asymptomatic 29-year-old with centripetal fill-in matches Hepatic hemangioma. The 34-year-old oral contraceptive user with a hemorrhaging subcapsular lesion matches Hepatic adenoma. The 31-year-old with a uniformly enhancing mass and a central stellate scar matches Focal nodular hyperplasia.
Accurate identification of solid liver lesions requires integrating patient demographics and risk factors with classic multiphasic imaging patterns. Hepatocellular carcinoma exhibits early arterial enhancement and rapid venous washout, typically in a cirrhotic liver. Hepatic hemangiomas show peripheral nodular, centripetal fill-in over time. Hepatic adenomas are heterogeneous, prone to hemorrhage, and linked to exogenous estrogen. Focal nodular hyperplasia features a hypervascular mass organized around a classic central stellate scar.
Step-by-Step Solution
Key Concept
Diagnosis of solid liver lesions using multiphasic CT/MRI contrast enhancement patterns and patient risk factors.